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Background: The etiology of primary cutaneous anaplastic large-cell CD30+ lymphoma is largely unknown, and
although an infectious involvement has been suspected, the implication of infectious agents in its pathogenesis is
still unclear.
Findings: We report the case of a HIV-negative patient referred to our hospital with a rapidly enlarging skin tumor
on her upper eyelid. Surgical excision was performed and histological analysis evidenced a primary cutaneous
anaplastic large-cell lymphoma. Due to the ocular localization and to the prominent angiogenic component of the
lesion, molecular analyses for the detection of Chlamydophila pneumoniae and HHV8 were performed, revealing the
presence of an infection by both pathogens in surgical biopsy and in peripheral blood mononuclear cells.
Conclusions: These findings suggest for the first time a possible association of C. pneumoniae and/or HHV8
infection, or both together, with primary cutaneous anaplastic large-cell lymphoma in non-immunocompromised
and HIV-negative subjects. This potential pathogenic association, if confirmed, could provide potential indications
for future therapy.
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The risk factors for the development of cutaneous
lymphomas are largely unknown. An infectious etiology
has been suspected and investigated [1], but the implica-
tion of infectious agents in the pathogenesis of cutaneous
lymphoproliferative disorders is still controversial.
Chlamydophila pneumoniae is an obligate intracellular
pathogen with a worldwide diffusion and high seropre-
valence in the adult population (50-70%) [2]. Although
C. pneumoniae is known to infect human keratinocytes
in vitro and to be associated with some cutaneous T cell
lymphomas (CTCLs) [3,4], its implication in the patho-
genesis of skin lymphomas remains unclear.* Correspondence: vri@unife.it
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reproduction in any medium, provided the orHuman herpesvirus 8 (HHV8) prevalence varies geo-
graphically [5], being significantly higher in HIV-infected
patients [6,7]. HHV8 is causally related to KS and is
associated to other malignancies, including Multicentric
Castleman’s Disease (MCD), Primary Effusion Lymph-
omas (PEL) and other lymphoproliferative disorders in
immunosuppressed patients [8]. In vivo, HHV8 has
been found in KS endothelial cells, in T and B lympho-
cytes, monocytes and keratinocytes, showing a broad
cell tropism [9].
Here we report the case of an immunocompetent
patient with a primary cutaneous anaplastic large-cell
lymphoma (PCALCL) characterized by the presence of
active C. pneumoniae and HHV8 infections.Case report
A 64-year-old woman presented at our Dermatology
outpatient Unit with a 6-week-history of a single, painless,Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.infectagentscancer.com/content/8/1/4126 mm in diameter rapidly enlarging skin tumor located
on her upper right eyelid (Figure 1). The lesion was ele-
vated, firm, of reddish-brown color, with well-defined
borders and central crater-like ulcero-necrotic depres-
sion covered with crust. No ocular involvement was
assessed. Physical examination was unremarkable and
there was no palpable lymphadenopathy. The patient’s
medical history included Hashimoto’s thyroiditis long-
term treated with levothyroxine and chronic urticaria
cyclically treated with oral antihistamine. At the onset,
the lesion had been treated with aspecific systemic and
topical antibiotics in the suspect of a pyodermitis, but
the clinical picture worsened. The patient complained
of about 2-week slight intermittent fever, sweats, and
itching but without weight loss.
Methods and results
A surgical excision of the lesion was performed at the
Ophthalmological Unit and histological examination re-
vealed diffuse lymphocytic infiltration of the dermis with
anaplastic lymphoid large cells (Figure 2). Tumor cells
presented irregular nucleus, frequent mitotic figures,
and were positive for CD3, CD2 and CD30, and negative
for CD5, CD56, ALK and CD20, as determined by im-
munohistochemistry. The Ki67/MIB-1 proliferation index
was about 90%. BIOMED-2 molecular analysis evidenced
monoclonal rearrangement of the TCR-γ gene. Systemic
evaluation including a positron emission tomography/
computed tomography scan of the body, bone marrow bi-
opsy, complete blood count with differential, and blood
chemistry including lactate dehydrogenase, showed no
evidence of extracutaneous involvement. Orbital mag-
netic resonance imaging also gave normal results. The
patient’s serum was negative for anti-HIV antibodies.
The diagnosis was primary cutaneous CD30+ anaplastic
large cell lymphoma.
Considering the ocular localization and the histological
features of the lesion, and the high potential ofFigure 1 Clinical features. (A) The skin tumor on patient’s upper right eyChlamydia and HHV8 in lymphoma induction, the local
and systemic presence of both pathogens was investi-
gated, after receiving informed consent from the patient.
The research has been carried out in compliance with
the Helsinki Declaration. Approval by the institutional re-
view board of our Hospital was not required for the
present study, as materials were not collected specifically
for this study, and were completely de-identified.
C. pneumoniae was searched in cutaneous biopsy and
in peripheral blood mononuclear cells (PBMCs) isolated
by density gradient from peripheral blood (Fycoll-paque
plus, GE Healthcare Europe GmbH, Milan, Italy). DNA
and RNA were extracted as previously described [10,11],
and assayed by PCR. A fraction of PBMCs was instead
centrifuged, suspended in RPMI 1640 medium (Gibco,
Invitrogen, Carlsbad, CA) and co-cultured up to 144 hours
with Hep-2 cell line (ATCC CCL-23), to increase the
number of bacterial inclusions [11]. Cultured samples
were then processed as done for fresh uncultured cells.
Analyses included nested-PCR and PCR after retro-
transcription (RT-PCR), using primer sets targeting 16S
rRNA, outer membrane protein (ompA/MOMP), and
HsP-60 genomic regions of C. psittaci, C. pneumoniae,
and C. trachomatis [11]. Amplification fragments, corre-
sponding to C. pneumoniae 16S rRNA gene, were found
both in tumor tissue and in co-cultured PBMCs (Figure 3).
Amplicons were sequenced by ABI PRISM 377 DNA
Sequencer (Applied Biosystems, The Netherlands) and
compared with other Chlamydiaceae genes [12], showing
a strict homology with C. pneumoniae TW183 strain
(AE009440.1, 99%; E value: < 0.01).
In parallel, the same specimens were also used for
HHV8 search, by PCR or real time quantitative PCR
(qPCR) specifically designed in three different regions of
HHV8 ORF50 and ORF26 genes [10]. The analysis of
three different gene segments was undertaken to avoid the
risk of false positive/negative results connected with a sin-
gle gene detection. Results showed that both tumor biopsyelid; (B) No relapse occurred 12 months after surgical excision.
Figure 2 Histological and immunohistochemical findings. (A) Diffuse lymphocytic infiltration of the dermis predominantly composed of large
pleomorphic cells with irregular nuclei and prominent nucleoli (hematoxylin-eosin staining, magnification 20×). By immunoperoxidase staining,
the neoplastic cells showed marked and diffuse expression of CD3 (B) and CD30 (C).
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Quantification of viral load, as determined by qPCR,
showed 1.24 × 103 virus genome copies per 100 ng total
DNA in tumor biopsy and 5 × 103 copies/100 ng DNA
in PBMCs. HHV8 DNA was detected also in the plasma
fraction of peripheral blood (Figure 4B), suggesting the
presence of virions released from productively infected
cells. Consistently with this, transcriptional analysis of
HHV8 in PBMCs showed the presence of lytic ORF50/
ORF26 transcripts, in addition to latent ORF73 mRNA,
demonstrating that HHV8 was actively replicating, as
ORF50/ORF26 genes are only expressed during the pro-
ductive phase of infection (Figure 4C). Since EBV infec-
tion has been associated to the occurrence of ocular
lymphomas, the specimens were also analyzed for the
presence of EBV, by specific nested PCR, obtaining
negative results.
Due to the detection of active chlamydial infection,
the patient was given doxycycline 100 mg, twice a day,
for 4 weeks. This treatment was safe and well tolerated,Figure 3 C. pneumoniae detection in tumor biopsy (T) and PBMCs (P). T
analyzed by PCR and RT-PCR for 16s RNA C. pneumoniae gene. Amplification c
respectively to DNA and RNA extracted from C. pneumoniae TW183 strain); Mand C. pneumoniae was no longer detectable in PBMCs
after the conclusion of antibiotic treatment.
Follow up analyses were performed after 12 months,
during which the patient has remained free of skin and
systemic disease. C. pneumoniae was no longer detect-
able in the patient’s PBMCs, and HHV8 was no longer
sustaining active infection, suggesting that the virus
entered the latent phase.
Discussion
Primary cutaneous CD30+ lymphoproliferative disorders
are the second most common form of CTCLs, including
PCALCL [13]. PCALCL usually occur as rapidly growing
and ulcerating large tumors, histologically characterized
by large tumor cells with an anaplastic, pleomorphic,
and immunoblastic cytomorphology, largely expressing
(>75%) CD30. In the etiology of CTCLs, a role for
superantigenic activation of T cells leading to accumula-
tion of skin-homing T cells has been suggested [14], and
defects in apoptosis signalling in skin-homing T cellsotal DNA and RNA were extracted by tissue specimen and PBMC and
ontrols include negative (C-) and positive controls (corresponding
arker 100 bp (M).
Figure 4 HHV8 presence in tumor biopsy and peripheral blood.
(A) Total DNA extracted from biopsy tissue (T) was analyzed by PCR for
HHV8 ORF50 and ORF26 genes. Amplification of the house-keeping
β-actin gene was included as a control, and DNA from a T cell line
negative for HHV8 (JJhan cells) and from a PEL-derived B cell line
latently infected by HHV8 (BCBL-1 cells) were respectively used as
negative (C-) and positive (C+) controls. Amplification controls also
included: blanks of extraction (B1) and amplification (B2). (B) Total DNA
extracted from PBMCs (P) and plasma (PL) fractions were analyzed as
described for tumor biopsy. (C) Total RNA extracted from PBMCs was
analyzed by RT-PCR for HHV8 lytic (ORF50, ORF26) and latent (ORF73)
genes. Negative (C-) and positive (C+) controls, and β-actin control
with (RT+) or without (RT-) previous retrotranscription are also shown.
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conclusive data are still lacking.
Accumulating evidence suggests that Chlamydia Spp.
may play a role in oncogenesis for their tendency to cause
persistent infections and chronic antigenic stimulation. C.
psittaci has been associated to ocular adnexal lymphomas
(OALs) of MALT-type [3]. C. pneumoniae has been shown
to be present in some CTCL and to induce the expansion
of C. pneumoniae-specific T cells throughout the release
of Sézary T cell-activating factor (SAF), thus potentiating
the development of CTCL [4]. C. pneumoniae eradication
with doxycycline has been reported to result in lymphoma
regression in about a half of patients [16], as also
evidenced for C. trachomatis, supposed to have a role in
ocular lymphoma [17]. Moreover, chlamydial infection hasbeen detected in some forms of cutaneous lymphomas
and in diffuse large B-cell lymphomas arising in the
Waldeyer’s ring [3].
On the other hand, several viruses have been investi-
gated as possible trigger agents of CTCLs, including her-
pesviruses. EBV infection was associated to extranodal
NK/T-cell lymphoma and some primary cutaneous lymph-
omas [18]. Cytomegalovirus infection was associated with
CTCLs [19], but the association is still controversial.
HHV8 was found in various tumors and lympho-
proliferative diseases [8], and the incidence of HHV8-
related tumors, even in populations with high HHV8
seroprevalence suggests the need for cofactors [20]. A
number of HHV8 genes are known to have effects in
cell proliferation and transformation [8], and accumu-
lating data point to the importance of lytic replication
for the development of HHV8-associated neoplastic
pathologies, as indicated by recent clinical studies [21].
Our data present evidence of a concurrent active infec-
tion by C. pneumoniae and HHV8 in a PCALCL patient,
suggesting for the first time a potential association of
chlamydial and HHV8 infection with the development
of the PCALCL. Although the possibility exists that it
might be simply accidental, the presence of both micro-
organisms is intriguing, and suggests that they might
reciprocally potentiate their pathogenic potential. This
hypothesis has been suggested for other pathologies
without obtaining clear conclusions [22,23], and may
deserve further investigation. In parallel, individual sus-
ceptibility might be important for the development of
the disease. We recently reported that specific Killer In-
hibitory Receptors (KIR) present on NK cells are related
to a decreased ability to control herpesviruses infection
[24], and it may be hypothesized that individuals with
an immune response not capable of controlling infectious
replication might be more susceptible to infection-related
tumor development.
Any consideration about the possible role of antibiotic
therapy in treating the neoplasm cannot be drawn, as
the antibiotic treatment was started when the tumor had
been surgically excised.
Studies of more patients would be needed to clarify
the role of pathogens in PCALCL development.
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